Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Update

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) was the target of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 6,100 shares, a growth of 125.9% from the November 30th total of 2,700 shares. Based on an average daily volume of 9,000 shares, the short-interest ratio is currently 0.7 days. Approximately 0.1% of the shares of the company are sold short.

Armata Pharmaceuticals Trading Up 4.5 %

Shares of Armata Pharmaceuticals stock opened at $2.11 on Friday. The firm has a market capitalization of $76.34 million, a P/E ratio of -1.29 and a beta of 0.78. Armata Pharmaceuticals has a one year low of $1.85 and a one year high of $4.48.

Wall Street Analyst Weigh In

Separately, HC Wainwright reissued a “buy” rating and issued a $7.00 price objective on shares of Armata Pharmaceuticals in a report on Thursday, December 19th.

Armata Pharmaceuticals Company Profile

Armata Pharmaceuticals, Inc, a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia.